Literature DB >> 22809815

Does posterior cortical atrophy on MRI discriminate between Alzheimer's disease, dementia with Lewy bodies, and normal aging?

James O'Donovan1, Rosie Watson, Sean J Colloby, Michael J Firbank, Emma J Burton, Robert Barber, Andrew M Blamire, John T O'Brien.   

Abstract

BACKGROUND: Previous studies suggest that posterior cortical atrophy may be a useful marker for early onset Alzheimer's disease (AD). Dementia with Lewy bodies (DLB) is associated with less temporal lobe atrophy than AD, though posterior cortical atrophy may be greater. Therefore, we assessed whether visual rating scales for assessing posterior atrophy (PA), medial temporal lobe atrophy (MTA), and ventricular enlargement (VEn) aid in the discrimination between AD, DLB, and normal aging.
METHODS: T1-weighted MRI scans acquired at 3 Tesla were visually rated for PA (range 0-3), MTA (range 0-4), and VEn (range 0-3) in older subjects with AD (n = 36), DLB (n = 35), and healthy controls (n = 35). The diagnostic utility of MTA, PA, and VEn visual ratings in distinguishing AD and DLB from controls as well as AD from DLB was investigated.
RESULTS: Significantly higher MTA ratings were associated with AD and DLB compared to controls (p < 0.001). MTA ratings were greater in AD relative to DLB (U = 384.5, p = 0.004). For PA ratings, scores did not differ between groups (p = 0.20). VEn ratings were significantly higher in AD and DLB compared to controls (p = 0.003), but similar between AD and DLB (U = 384.5, p = 0.4).
CONCLUSIONS: Unlike findings reported in younger subjects, visual ratings for PA are not a reliable marker at older ages for distinguishing AD from controls, or for distinguishing DLB from AD. However, visual ratings of MTA and VEn may be useful markers in distinguishing both AD and DLB from older subjects without dementia.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22809815     DOI: 10.1017/S1041610212001214

Source DB:  PubMed          Journal:  Int Psychogeriatr        ISSN: 1041-6102            Impact factor:   3.878


  12 in total

1.  Pattern of brain atrophy rates in autopsy-confirmed dementia with Lewy bodies.

Authors:  Zuzana Nedelska; Tanis J Ferman; Bradley F Boeve; Scott A Przybelski; Timothy G Lesnick; Melissa E Murray; Jeffrey L Gunter; Matthew L Senjem; Prashanti Vemuri; Glenn E Smith; Yonas E Geda; Jonathan Graff-Radford; David S Knopman; Ronald C Petersen; Joseph E Parisi; Dennis W Dickson; Clifford R Jack; Kejal Kantarci
Journal:  Neurobiol Aging       Date:  2014-07-15       Impact factor: 4.673

2.  Characterizing dementia with Lewy bodies by means of diffusion tensor imaging.

Authors:  Rosie Watson; Andrew M Blamire; Sean J Colloby; Josh S Wood; Robert Barber; Jiabao He; John T O'Brien
Journal:  Neurology       Date:  2012-08-15       Impact factor: 9.910

3.  Brain metabolic signatures across the Alzheimer's disease spectrum.

Authors:  Arianna Sala; Camilla Caprioglio; Roberto Santangelo; Emilia Giovanna Vanoli; Sandro Iannaccone; Giuseppe Magnani; Daniela Perani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-12-07       Impact factor: 9.236

Review 4.  Posterior cortical atrophy: review of the recent literature.

Authors:  François-Xavier Borruat
Journal:  Curr Neurol Neurosci Rep       Date:  2013-12       Impact factor: 5.081

5.  Cortical Thickness in Dementia with Lewy Bodies and Alzheimer's Disease: A Comparison of Prodromal and Dementia Stages.

Authors:  Frederic Blanc; Sean J Colloby; Nathalie Philippi; Xavier de Pétigny; Barbara Jung; Catherine Demuynck; Clélie Phillipps; Pierre Anthony; Alan Thomas; Fabrice Bing; Julien Lamy; Catherine Martin-Hunyadi; John T O'Brien; Benjamin Cretin; Ian McKeith; Jean-Paul Armspach; John-Paul Taylor
Journal:  PLoS One       Date:  2015-06-10       Impact factor: 3.240

Review 6.  Structural MR Imaging in the Diagnosis of Alzheimer's Disease and Other Neurodegenerative Dementia: Current Imaging Approach and Future Perspectives.

Authors:  Mina Park; Won-Jin Moon
Journal:  Korean J Radiol       Date:  2016-10-31       Impact factor: 3.500

7.  MRI Visual Ratings of Brain Atrophy and White Matter Hyperintensities across the Spectrum of Cognitive Decline Are Differently Affected by Age and Diagnosis.

Authors:  Hanneke F M Rhodius-Meester; Marije R Benedictus; Mike P Wattjes; Frederik Barkhof; Philip Scheltens; Majon Muller; Wiesje M van der Flier
Journal:  Front Aging Neurosci       Date:  2017-05-09       Impact factor: 5.750

8.  Comprehensive Visual Rating Scale on Magnetic Resonance Imaging: Application to Prodromal Alzheimer Disease.

Authors:  Jae Kyung Chung; Jae-Won Jang
Journal:  Ann Geriatr Med Res       Date:  2021-03-15

9.  A Pilot Study on Clinical and Neuroimaging Characteristics of Chinese Posterior Cortical Atrophy: Comparison with Typical Alzheimer's Disease.

Authors:  Xiao-Dan Wang; Hui Lu; Zhihong Shi; Li Cai; Shuai Liu; Shuling Liu; Tong Han; Ying Wang; Yuying Zhou; Xinping Wang; Shuo Gao; Yong Ji
Journal:  PLoS One       Date:  2015-08-12       Impact factor: 3.240

10.  Multimodal EEG-MRI in the differential diagnosis of Alzheimer's disease and dementia with Lewy bodies.

Authors:  Sean J Colloby; Ruth A Cromarty; Luis R Peraza; Kristinn Johnsen; Gísli Jóhannesson; Laura Bonanni; Marco Onofrj; Robert Barber; John T O'Brien; John-Paul Taylor
Journal:  J Psychiatr Res       Date:  2016-03-25       Impact factor: 4.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.